Analyst Ratings for Roche (RHHBY)
RHHBY Rating Summary
RHHBY Price Target Summary
- Highest: $39.00 (Morgan Stanley)
- Lowest: $39.00 (Morgan Stanley)
- Average: $39.00
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$39.00 (-29.6%)
* Over Last 12-Mos
Rating Score: 2 / 10
Percentile Rank: 15%
Avg. $ Target:
$39.00 (-29.6%)
* Over Last 12-Mos
Rating Score: 2 / 10
Percentile Rank: 15%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/8/2025 | Morgan Stanley | Sarita Kapila | Downgrade | Underweight (Equalweight) |
39.00 (44.00) |
38.36 (55.39) |
44.4% | Details |
| 12/9/2024 | CFRA | Wan Nurhayati | New Coverage | Hold (N/A) |
40.00 (N/A) |
36.51 (55.39) |
51.71% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
